A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma

R. Kessler, Elizabeth; Callihan, Eryn; Hu, Junxiao; Eule, Corbin; Srivastava, Geetika; J. Kemme, Douglas; Iruku, Praveena; Rana, Vishal; Moore, James; R. Schuster, Steven; Amirault, Mali; W. Flaig, Thomas; T. Lam, Elaine

doi:10.1158/2767-9764.crc-23-0060

Public

A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma

Published in Cancer Research Communications • May 24, 2023

Authors:

Elizabeth R. Kessler

Eryn Callihan

Junxiao Hu

Abstract

Purpose: Immune checkpoint inhibitor and VEGFR inhibitor combinations are effective treatments for patients with metastatic renal cell carcinoma (mRCC). This phase I/II clinical trial evaluated the safety and efficacy of pembrolizumab and cabozantinib in patients with mRCC. Experimental Design: Elig...

Subject

Medicine

Pembrolizumab

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!